Cleared Traditional

K900596 - ACUDATA INDICATENS MODEL 5A

K900596 is an FDA 510(k) clearance for ACUDATA INDICATENS MODEL 5A, manufactured by Acudata Software. The device is a Class 2 Neurology device with product code GZJ cleared through the Traditional 510(k) pathway after a 134-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 1990
Decision
134d
Days
Class 2
Risk

K900596 is an FDA 510(k) clearance for the ACUDATA INDICATENS MODEL 5A. Classified as Stimulator, Nerve, Transcutaneous, For Pain Relief (product code GZJ), Class II - Special Controls.

Submitted by Acudata Software (Penngrove, US). The FDA issued a Cleared decision on June 22, 1990 after a review of 134 days - within the typical 510(k) review window.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.5890 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

FDA 510(k) Submission Details - K900596

510(k) Number K900596 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 08, 1990
Decision Date June 22, 1990
Days to Decision 134 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
15d faster than avg
Panel avg: 149d · This submission: 134d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GZJ Device Classification - Class 2, Special Controls

Product Code GZJ Stimulator, Nerve, Transcutaneous, For Pain Relief
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.5890
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - GZJ Stimulator, Nerve, Transcutaneous, For Pain Relief

All 605
Devices cleared under the same product code (GZJ) and FDA review panel - the closest regulatory comparables to K900596.
ELECTROSTIM MST
K901417 · Promatek Industries, Ltd. · Aug 1990
LUMISCOPE MICRO 100
K901726 · Lumiscope Co., Inc. · Aug 1990
TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION
K896787 · Saratoga Intl., Inc. · Jul 1990
ACUDATA INDICATENS MODEL 5XS
K900668 · Acudata Software · Jun 1990
NEUROTENS
K896620 · Henley Intl. · Apr 1990
LISS BODY STIMULATOR MODEL SBL501-M
K896226 · Medical Consultants Intl. , Ltd. · Apr 1990